NEWS
CFO Dive I Ratio Therapeutics CFO gets due-diligence ready

Fresh from closing a $20 million series A financing in December, biotech firm Ratio Therapeutics’ new CFO is focused on helping his young company build a sophisticated finance department. Before Reed Malleck, the company’s finance chief, arrived in October there was a part-time contract CFO, a part-time contract controller and four or five people in the company […]

MedTech Dive I Onshoring, easing labor market expected to drive double-digit growth at US medtech CDMOs

The U.S. medtech contract development and manufacturing organization (CDMO) market will grow 12.9% this year, according to a report by healthcare advisory and clinical research firm Alira Health and the Massachusetts Medical Device Industry Council (MassMEDIC). Robust fundamentals, “a steady onshoring trend of critical manufacturing processes,” and the easing of the labor market as the economic recession […]

PharmaVoice I A biotech CEO’s favorite ‘F’ word

Who’s the boss? For SFA Therapeutics’ CEO and co-founder Ira Spector it’s patients, and his sights are set on changing the course of treatment for chronic inflammatory disease. A 30-year industry veteran with extensive drug development expertise running clinical trials at Wyeth (now part of Pfizer), Allergan and ICON, Spector could be sitting comfortably on […]